Japan Cancer Biopsy Market Size & Outlook, 2023-2030

The cancer biopsy market in Japan is expected to reach a projected revenue of US$ 2,307.9 million by 2030. A compound annual growth rate of 11.6% is expected of Japan cancer biopsy market from 2024 to 2030.
Revenue, 2023 (US$M)
$1,070.5
Forecast, 2030 (US$M)
$2,307.9
CAGR, 2024 - 2030
11.6%
Report Coverage
Japan

Japan cancer biopsy market highlights

  • The Japan cancer biopsy market generated a revenue of USD 1,070.5 million in 2023 and is expected to reach USD 2,307.9 million by 2030.
  • The Japan market is expected to grow at a CAGR of 11.6% from 2024 to 2030.
  • In terms of segment, kits and consumables was the largest revenue generating product in 2023.
  • Instruments is the most lucrative product segment registering the fastest growth during the forecast period.


Cancer biopsy market data book summary

Market revenue in 2023USD 1,070.5 million
Market revenue in 2030USD 2,307.9 million
Growth rate11.6% (CAGR from 2023 to 2030)
Largest segmentKits and consumables
Fastest growing segmentInstruments
Historical data2018 - 2022
Base year2023
Forecast period2024 - 2030
Quantitative unitsRevenue in USD million
Market segmentationInstruments, Kits and Consumables, Services
Key market players worldwideQiagen NV, Illumina Inc, Becton Dickinson & Co, ANGLE PLC, Myriad Genetics Inc, Hologic Inc, Biocept Inc, Thermo Fisher Scientific Inc, Danaher Corp, Roche Holding AG, Guardant Health Inc, Exact Sciences Corp, Biodesix Inc Ordinary Shares, Epigenomics AG, OncoCyte Corp, Natera Inc, Personalis Inc, Labcorp Holdings Inc, Helio Health


Other key industry trends

  • In terms of revenue, Japan accounted for 3.6% of the global cancer biopsy market in 2023.
  • Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
  • In Asia Pacific, China cancer biopsy market is projected to lead the regional market in terms of revenue in 2030.
  • China is the fastest growing regional market in Asia Pacific and is projected to reach USD 3,146.7 million by 2030.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Cancer Biopsy Market Companies

Name Profile # Employees HQ Website

Japan cancer biopsy market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to cancer biopsy market will help companies and investors design strategic landscapes.


Kits and consumables was the largest segment with a revenue share of 61.46% in 2023. Horizon Databook has segmented the Japan cancer biopsy market based on instruments, kits and consumables, services covering the revenue growth of each sub-segment from 2018 to 2030.


Reasons to subscribe to Japan cancer biopsy market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of Japan cancer biopsy market databook

  • Our clientele includes a mix of cancer biopsy market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of country-level data and insights on the Japan cancer biopsy market , including forecasts for subscribers. This country databook contains high-level insights into Japan cancer biopsy market from 2018 to 2030, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

Japan cancer biopsy market size, by product, 2018-2030 (US$M)

Japan Cancer Biopsy Market Outlook Share, 2023 & 2030 (US$M)

Japan cancer biopsy market size, by product, 2018-2030 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more